GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Insider Ownership

Immunocore Holdings (Immunocore Holdings) Insider Ownership : 0.07 % (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Immunocore Holdings's insider ownership is 0.07%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Immunocore Holdings's Institutional Ownership is 37.29%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Immunocore Holdings's Float Percentage Of Total Shares Outstanding is 87.75%.

Immunocore Holdings Insider Ownership Historical Data

The historical data trend for Immunocore Holdings's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Insider Ownership Chart

Immunocore Holdings Historical Data

The historical data trend for Immunocore Holdings can be seen below:

2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Insider Ownership 0.07 0.07 0.07 0.07 0.07

Immunocore Holdings Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Insider Ownership
Comparable Companies
XTER:BIO XTER:MOR XTER:FYB XTER:HPHA XTER:BNN STU:9DF XTER:MDG1 XTER:T5O OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE
Traded in Other Exchanges
6YG:Germany 6YG:Germany
Address
92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY
Website
https://www.immunocore.com
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.